New temporary drugs to replace immunosuppressant drugs
Published on December 22, 2014

JDRF partner Viacyte, a US-based regenerative medicine company, has successfully transplanted human pancreatic tissue into mice without immune rejection of the tissue. In this new preliminary study, stem cell-derived immature pancreatic cells were transplanted into mice that had their own beta-cells chemically destroyed. The mice were treated with drugs for two weeks that block specific […]

JDRF-funded researcher part of international study
Published on December 17, 2014

JDRF-funded Australian scientist Professor Nathan Efron from the Queensland University of Technology, along with other international researchers and research institutions, has been awarded a combined US$1.1 million from the National Institutes of Health (NIH) in the US. This international multi-site multi-disciplinary project grant is for a new study entitled “’Multinational Collaborative Evaluation of Corneal Confocal […]

Enteroviruses may be linked to the development of T1D
Published on December 12, 2014

Taiwanese researchers have analysed health insurance records in a large, nationwide study and discovered that the incidence of type 1 diabetes (T1D) was 50% higher in children who had previously been infected with enterovirus when compared with children who had never been infected. This study is particularly noteworthy, as Taiwan traditionally has a very low […]

1 10 11 12